Changes

no edit summary
Line 1: Line 1:  +
{{DISPLAYTITLE:Hairy Cell Leukemia Variant}}
 +
 +
 +
<blockquote class='blockedit'>{{Box-round|title=PREVIOUS EDITION|This page from the 4th edition of Haematolymphoid Tumours is being updated. See 5th edition [[HAEM5:Table_of_Contents|Table of Contents]].
 +
}}</blockquote>
 
==Primary Author(s)*==
 
==Primary Author(s)*==
   Line 6: Line 11:  
==Cancer Category/Type==
 
==Cancer Category/Type==
   −
*[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]]
+
*[[HAEM4:Splenic B-cell Lymphoma/Leukemia, Unclassifiable]]
    
==Cancer Sub-Classification / Subtype==
 
==Cancer Sub-Classification / Subtype==
Line 15: Line 20:     
*HCLv is a rare chronic neoplasm of B-cell origin seen mostly in adults
 
*HCLv is a rare chronic neoplasm of B-cell origin seen mostly in adults
*Name derives from clinicopathologic similarity to [[Hairy Cell Leukemia|hairy cell leukemia]] (HCL) but with important differences
+
*Name derives from clinicopathologic similarity to [[HAEM5:Hairy cell leukaemia|hairy cell leukemia]] (HCL) but with important differences
 
*Marked splenomegaly and marrow infiltration result in left flank discomfort, fatigue, and susceptibility to infections
 
*Marked splenomegaly and marrow infiltration result in left flank discomfort, fatigue, and susceptibility to infections
 
*Most respond poorly to monotherapy with a purine analog or interferon alpha (used for HCL)
 
*Most respond poorly to monotherapy with a purine analog or interferon alpha (used for HCL)
Line 74: Line 79:  
|Positive||CD11c, CD72, CD103
 
|Positive||CD11c, CD72, CD103
 
|-
 
|-
|Negative ([[Hairy Cell Leukemia|HCL]] markers)||CD25, CD123, annexin A1, TRAP, BRAF V600E
+
|Negative ([[HAEM5:Hairy cell leukaemia|HCL]] markers)||CD25, CD123, annexin A1, TRAP, BRAF V600E
 
|-
 
|-
 
|Negative
 
|Negative
Line 219: Line 224:  
==Links==
 
==Links==
   −
*[[Hairy Cell Leukemia]]
+
*[[HAEM5:Hairy cell leukaemia]]
*[[Splenic Diffuse Red Pulp Small B-cell Lymphoma]]
+
*[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]]
    
==References==
 
==References==
Line 231: Line 236:  
==Notes==
 
==Notes==
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
 +
[[Category:HAEM4]] [[Category:DISEASE]]